LianBio [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q/A	10-Q
Revenues	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	-14.4	0.0	0.0	0.0	0.0	0.0
Gross margin			-187.9%
Selling, general and administrative [+]	15.6	15.1	14.4	14.6	16.1	14.4	8.9	6.5
General and administrative	15.6	15.1	14.4	14.6	16.1	14.4	8.9	6.5
Research and development	9.5	10.8		28.6	12.3	7.7	4.7	93.0
Other operating expenses			-6.7
EBITDA [+]	-24.7	-25.6		-43.0	-28.1	-21.8	-13.4	-99.4
EBITDA growth	-42.5%	-8.9%	1.1%	-56.7%	-53.4%	137.9%	-88.7%
EBITDA margin			-287.9%
Depreciation and amortization	0.3	0.3		0.1	0.3	0.2	0.1	0.1
EBIT [+]	-25.0	-26.0	-22.0	-43.1	-28.4	-22.0	-13.5	-99.5
EBIT growth	-41.9%	-8.6%	0.0%	-56.6%	-53.0%	139.4%	-88.6%
EBIT margin			-287.9%
Interest income	2.8	2.4	0.1	0.6	0.3	0.1	0.0	0.1
Interest income	2.8	2.4	0.1	0.6	0.3	0.1	0.0	0.1
Other income (expense), net	1.1	0.4	-0.3	0.2	0.4	-1.8	-0.4	0.9
Pre-tax income	-21.2	-23.2	-22.2	-42.4	-27.7	-23.8	-13.9	-98.5
Income taxes	0.2	0.4	-1.0	0.0	0.0	-1.0	-0.4	1.0
Tax rate			4.7%			4.4%	2.9%
Net income	-21.4	-23.6	-21.2	-42.4	-27.7	-22.2	-13.5	-99.5
Net margin			-276.9%

Basic EPS [+]	($0.20)	($0.22)		($0.39)	($0.26)	($0.65)	($0.65)	($4.86)
Growth	-49.1%	-14.7%		-91.9%	-91.3%	-38.8%	-94.4%
Diluted EPS [+]	($0.20)	($0.22)		($0.39)	($0.26)	($0.65)	($0.65)	($4.86)
Growth	-49.1%	-14.7%		-91.9%	-91.3%	-38.8%	-94.4%

Shares outstanding (basic) [+]	107.2	107.2		107.9	107.3	34.4	20.7	20.5
Growth	-0.7%	-0.1%		427.0%	423.9%	185.4%	101.6%
Shares outstanding (diluted) [+]	107.2	107.2		107.9	107.3	34.4	20.7	20.5
Growth	-0.7%	-0.1%		427.0%	423.9%	185.4%	101.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.